Article questions Eli Lilly marketing push

Eli Lilly and Co. funded medical guidelines created for the treatment of a deadly infection in an effort to boost sales of a drug with questionable benefits, according to an article in today's issue of the New England Journal of Medicine . (Full article: 558 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

• $4.95 1 article
• $9.95 4 articles
• $25.95 Monthly